Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work
Max Robinson(Newcastle University), Clare Verrill(University of Oxford), Philip Sloan(Newcastle University), Nicholas P. West(Johannes Gutenberg University Mainz), Jacqueline A. James(Queen's University Belfast), Alex Freeman(University College London), Gareth J. Thomas(University of Southampton), J. Louise Jones(Queen Mary University of London), Philip Elliot(Queen Mary University of London), Karin A. Oien(NHS Greater Glasgow and Clyde), Jessica Lee(Development Initiatives), Manuel Rodriguez‐Justo(CRUK Lung Cancer Centre of Excellence), C. E. H. Craig(Genomics England), Maggie C.U. Cheang(Institute of Cancer Research)
Cited by 30
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
|Clinical Cancer Research|2008|1.2k
Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer
|Oral Diseases|2020|1.1k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
|The Oncologist|2013|548